Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Hansa Biopharma

29.52 SEK

+0.14 %

Less than 1K followers

HNSA

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Hansa Biopharma

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue48.732.3171.366.449.130.876.0222.3
EBITDA-116.9-173.7-637.4-93.4-154.8-147.6-124.9-520.7
EBIT-116.9-173.7-637.4-93.4-154.8-147.6-124.9-520.7
EBIT-%-240.3 %-537.0 %-372.0 %-140.8 %-315.1 %-479.2 %-164.4 %-234.3 %
Profit before taxes-103.7-273.6-803.7-36.7-178.0-147.6-164.6-527.0
Net income-103.8-276.4-806.7-37.1-178.9-148.3-165.0-529.3
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.